Human cohort studies consistently show that offspring exposed to intrauterine hyperglycemia (from GDM, T2D, or type 1 diabetes) are at increased risk of obesity, insulin resistance, impaired insulin secretion, T2D, and cardiovascular dysfunction compared to children from the background population. The gene discussed is INS; the disease is obesity disorder.